 |
|
The Influence of NAT2 Genotypes on Isoniazid Plasma Concentration of Pulmonary Tuberculosis Patients in Southern Thailand
Usanee Ungcharoen, Hutcha Sriplung, Surakameth Mahasirimongkol, Saranyou Chusri, Nuanjun Wichukchinda, Phongpan Mokmued, Sukanya Wattanapokayakit, Virasakdi Chongsuvivatwong
Tuberc Respir Dis. 2020;83(Supple 1):S55-S62. Published online 2020 Nov 3 DOI: https://doi.org/10.4046/trd.2020.0068
|
|
Citations to this article as recorded by
Influence of
N
-acetyltransferase 2 polymorphisms and clinical variables on liver function profile of tuberculosis patients
Levin Thomas, Arun Prasath Raju, S. Chaithra, Shrivathsa Kulavalli, Muralidhar Varma, Chidananda Sanju SV, Mithu Baneerjee, Kavitha Saravu, Surulivelrajan Mallayasamy, Mahadev Rao
Expert Review of Clinical Pharmacology.2024; 17(3): 263. CrossRef Efficacy, safety, and pharmacokinetics of isoniazid affected by NAT2 polymorphisms in patients with tuberculosis: A systematic review
Thanakorn Surarak, Supatat Chumnumwat, Wichit Nosoongnoen, Pramote Tragulpiankit
Clinical and Translational Science.2024;[Epub] CrossRef The impact of IDH and NAT2 gene polymorphisms in acute myeloid leukemia risk and overall survival in an Arab population: A case-control study
Sohaib M. Al-Khatib, Obada Ababneh, Hassann Abushukair, Nour Abdo, Laith N. Al-Eitan, Alvaro Galli
PLOS ONE.2023; 18(7): e0289014. CrossRef Role of Pharmacogenomics in Reducing the Risk of Drug-Related Iatrogenesis
Veronique Michaud, Lucy I. Darakjian, Pamela Dow, Jacques Turgeon
Current Pharmacology Reports.2022; 8(2): 79. CrossRef
|